These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2472965)
1. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA). Lowy MT; Nash JF; Meltzer HY Eur J Pharmacol; 1989 Apr; 163(1):157-61. PubMed ID: 2472965 [TBL] [Abstract][Full Text] [Related]
2. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. Nash JF; Meltzer HY; Gudelsky GA J Neurochem; 1990 Mar; 54(3):1062-7. PubMed ID: 1689375 [TBL] [Abstract][Full Text] [Related]
3. Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Hiramatsu M; Cho AK Neuropharmacology; 1990 Mar; 29(3):269-75. PubMed ID: 1691459 [TBL] [Abstract][Full Text] [Related]
4. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
5. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. Nash JF; Meltzer HY; Gudelsky GA J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523 [TBL] [Abstract][Full Text] [Related]
6. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats. Nash JF; Arora RC; Schreiber MA; Meltzer HY Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. Gazzara RA; Takeda H; Cho AK; Howard SG Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036 [TBL] [Abstract][Full Text] [Related]
8. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD; Nichols DE; Yim GK Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126 [TBL] [Abstract][Full Text] [Related]
9. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat. Johnson M; Hanson GR; Gibb JW Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629 [TBL] [Abstract][Full Text] [Related]
10. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Stone DM; Hanson GR; Gibb JW Neuropharmacology; 1987 Nov; 26(11):1657-61. PubMed ID: 2448703 [TBL] [Abstract][Full Text] [Related]
11. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Schmidt CJ; Levin JA; Lovenberg W Biochem Pharmacol; 1987 Mar; 36(5):747-55. PubMed ID: 2881549 [TBL] [Abstract][Full Text] [Related]
13. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631 [TBL] [Abstract][Full Text] [Related]
14. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds. Colado MI; Green AR Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800 [TBL] [Abstract][Full Text] [Related]
15. Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations. Johnson M; Bush LG; Hanson GR; Gibb JW Biochem Pharmacol; 1993 Aug; 46(4):770-2. PubMed ID: 8103327 [TBL] [Abstract][Full Text] [Related]
16. A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates. Hiramatsu M; DiStefano E; Chang AS; Cho AK Eur J Pharmacol; 1991 Nov; 204(2):135-40. PubMed ID: 1725282 [TBL] [Abstract][Full Text] [Related]
17. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Farfel GM; Vosmer GL; Seiden LS Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Johnson M; Stone DM; Bush LG; Hanson GR; Gibb JW Eur J Pharmacol; 1989 Feb; 161(2-3):181-8. PubMed ID: 2470597 [TBL] [Abstract][Full Text] [Related]
19. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats. Yeh SY; Hsu FL Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801 [TBL] [Abstract][Full Text] [Related]
20. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Battaglia G; Yeh SY; De Souza EB Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]